Related Experiment Videos
Urolithiasis in patients with a jejunoileal bypass
Summary
Jejunoileal bypass surgery can lead to urinary stones. Long-term oral calcium supplementation appears to prevent urolithiasis in patients undergoing this procedure, with recent patients remaining stone-free.
Area of Science:
- Nephrology
- Gastroenterology
- Surgical Outcomes
Background:
- Jejunoileal bypass (JIB) surgery was historically used for morbid obesity.
- Postoperative urinary calculi (kidney stones) are a known complication of JIB.
- The exact incidence and preventative measures for urolithiasis after JIB require further investigation.
Purpose of the Study:
- To investigate the incidence of urinary calculi in patients following jejunoileal bypass.
- To explore potential correlations between postoperative factors and urolithiasis.
- To evaluate the efficacy of calcium supplementation in preventing urinary stones post-JIB.
Main Methods:
- Retrospective study of 517 patients who underwent jejunoileal bypass.
- Analysis of complete data from 365 patients to determine stone formation incidence.
- Comparison of stone incidence in patients with and without long-term oral calcium supplementation.
Main Results:
- A 9% incidence of urinary calculi was observed in the studied patient cohort.
- Men exhibited a higher prevalence of urolithiasis compared to women.
- Patients receiving long-term oral calcium supplementation showed a delay in symptomatic urolithiasis onset and remained stone-free for up to 12 months post-operation.
Conclusions:
- Jejunoileal bypass is associated with a significant risk of urinary stone formation.
- Oral calcium supplementation may serve as a preventative strategy against urolithiasis in post-JIB patients.
- Further research into calcium's role in preventing urolithiasis after bariatric procedures is warranted.